Stanker James H

Stanker James H is listed in filings as Chief Financial Officer at Processa Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Aug 2, 2024, including 5 public disclosures. Recent filings connect the profile to Processa Pharmaceuticals, Inc. (PCSA). The current snapshot covers public activity from Aug 2, 2024. Reported amounts are shown as $482. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.